Thai testing campaign suggests how local cultures can influence testing behaviour
Bone loss slows, but continues long-term in HIV-positive people on antiretroviral therapy
Asymptomatic neurocognitive impairment in people with HIV does predict later neurocognitive symptoms
Rilpivirine + darunavir HIV maintenance regimen matches standard three-drug antiretroviral therapy
Oestrogen may block HIV reactivation, hints at gender differences in viral reservoirs
HIV treatment as prevention scale-up linked to reduced mortality among people who inject drugs in Vancouver
HIV-positive youth are less likely than adults to achieve viral suppression on antiretroviral treatment
Fatty liver may contribute to higher risk of death for HIV/HCV co-infected people
People with HIV and hepatitis B co-infection can safely switch to simpler TAF single-tablet regimen
People with hepatitis B can safely use Truvada PrEP for HIV prevention
First Brazilian PrEP data reinforce evidence that PrEP is most used by those at greatest risk
Indiana HIV outbreak offers lessons about containing local outbreaks and need for harm reduction
WAVES shows elvitegravir regimen beats boosted atazanavir for women with HIV
Open-label PrEP in Botswana: very high adherence and no HIV infections seen
Peer or community interventions improve outcomes for mothers with HIV
Daclatasvir plus sofosbuvir cures HCV for most people with HIV and HCV co-infection in French compassionate use programme
Interferon-free hepatitis treatment is highly effective for people with HIV and HCV co-infection in three studies
